[go: up one dir, main page]

FR2397191A1 - STABLE PREPARATION OF CHLORAMPHENICOL FOR INJECTIONS - Google Patents

STABLE PREPARATION OF CHLORAMPHENICOL FOR INJECTIONS

Info

Publication number
FR2397191A1
FR2397191A1 FR7819873A FR7819873A FR2397191A1 FR 2397191 A1 FR2397191 A1 FR 2397191A1 FR 7819873 A FR7819873 A FR 7819873A FR 7819873 A FR7819873 A FR 7819873A FR 2397191 A1 FR2397191 A1 FR 2397191A1
Authority
FR
France
Prior art keywords
chloramphenicol
injections
stable preparation
pyrrolidone
stable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7819873A
Other languages
French (fr)
Other versions
FR2397191B1 (en
Inventor
Morris E Stolar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abic Ltd
Original Assignee
Abic Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abic Ltd filed Critical Abic Ltd
Publication of FR2397191A1 publication Critical patent/FR2397191A1/en
Application granted granted Critical
Publication of FR2397191B1 publication Critical patent/FR2397191B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Préparation stable de chloramphénicol pour injections. Pour stabiliser des solutions de chloramphénicol dans la N-méthyl-pyrrolidone, on y incorpore 4 à 20 % et de préférence 5 à 10 % en poids de polyvinyl-pyrrolidone. L'addition de cette substance permet en outre de préparer des préparations avec des concentrations en chloramphenicol allant jusqu'à 60% et de réduire par conséquent les volumes à injecter. Application à la médecine vétérinaire.Stable preparation of chloramphenicol for injections. To stabilize solutions of chloramphenicol in N-methyl-pyrrolidone, 4 to 20% and preferably 5 to 10% by weight of polyvinyl-pyrrolidone are incorporated therein. The addition of this substance also makes it possible to prepare preparations with chloramphenicol concentrations of up to 60% and consequently to reduce the volumes to be injected. Application to veterinary medicine.

FR7819873A 1977-07-15 1978-07-04 STABLE PREPARATION OF CHLORAMPHENICOL FOR INJECTIONS Granted FR2397191A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL52533A IL52533A (en) 1977-07-15 1977-07-15 Injectable chloramphenicol composition

Publications (2)

Publication Number Publication Date
FR2397191A1 true FR2397191A1 (en) 1979-02-09
FR2397191B1 FR2397191B1 (en) 1981-12-31

Family

ID=11049656

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7819873A Granted FR2397191A1 (en) 1977-07-15 1978-07-04 STABLE PREPARATION OF CHLORAMPHENICOL FOR INJECTIONS

Country Status (13)

Country Link
JP (1) JPS5420125A (en)
AT (1) AT360149B (en)
AU (1) AU3752578A (en)
BE (1) BE869001A (en)
CA (1) CA1112572A (en)
DE (1) DE2829408A1 (en)
FR (1) FR2397191A1 (en)
GB (1) GB2000970B (en)
IE (1) IE47126B1 (en)
IL (1) IL52533A (en)
NL (1) NL7807641A (en)
NZ (1) NZ187683A (en)
ZA (1) ZA783671B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ194192A (en) * 1979-07-02 1982-11-23 Pfizer Long-acting injectable composition containing sulfadimethoxine or sulfamethazine
NL8002636A (en) * 1980-05-08 1981-12-01 Gist Brocades Nv SOLOATE OF AMOXICILLINE, METHOD FOR PREPARING IT AND METHOD FOR PREPARING INJECTION PREPARATIONS FROM THIS SOLVATE
NL178941C (en) * 1982-06-15 1986-06-16 Aesculaap Bv PROCESS FOR PREPARING AN AQUEOUS OXYTETRACYCLINE PREPARATION.
JPS6031189A (en) * 1983-07-30 1985-02-16 カシオ計算機株式会社 musical tone generator
US4696814A (en) * 1985-08-21 1987-09-29 Warner-Lambert Company Parenteral phenytoin compositions
IT1197481B (en) * 1986-09-15 1988-11-30 Zambon Spa PHARMACEUTICAL PREPARATION FOR VETERINARY USE
US20030068339A1 (en) * 2001-10-02 2003-04-10 Phoenix Scientific, Inc. Veterinary florfenicol formulation that is syringeable under cold weather conditions
SI1830885T1 (en) 2004-12-21 2009-02-28 Intervet Int Bv Injectable veterinary composition comprising florfenicol
CN113694018A (en) * 2021-09-08 2021-11-26 海南制药厂有限公司制药二厂 Chloramphenicol injection and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2313080A1 (en) * 1975-04-11 1976-12-31 Nelson Res & Dev TOPICAL COMPOSITION FOR THERAPEUTIC AND COSMETIC TREATMENT AND PROCESS FOR PREPARATION

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2313080A1 (en) * 1975-04-11 1976-12-31 Nelson Res & Dev TOPICAL COMPOSITION FOR THERAPEUTIC AND COSMETIC TREATMENT AND PROCESS FOR PREPARATION

Also Published As

Publication number Publication date
ATA511878A (en) 1980-05-15
FR2397191B1 (en) 1981-12-31
CA1112572A (en) 1981-11-17
IE47126B1 (en) 1983-12-28
BE869001A (en) 1979-01-15
IE781425L (en) 1979-01-15
IL52533A0 (en) 1977-10-31
AU3752578A (en) 1980-01-03
DE2829408A1 (en) 1979-02-01
AT360149B (en) 1980-12-29
NL7807641A (en) 1979-01-17
ZA783671B (en) 1979-06-27
NZ187683A (en) 1981-03-16
GB2000970B (en) 1982-03-17
GB2000970A (en) 1979-01-24
IL52533A (en) 1980-01-31
JPS5420125A (en) 1979-02-15

Similar Documents

Publication Publication Date Title
SE8601624D0 (en) NEW PHARMACEUTICAL PREPARATIONS
DK235088D0 (en) PROCEDURE FOR TREATING SYMPTOMS OF NICOTIN ABSTINE AND PREPARATIONS FOR USE THEREOF
IL97411A (en) Pharmaceutical formulations comprising hapten-modified diagnostic or therapeutic agents
NO175704C (en) Process for the preparation of a stable pharmaceutical preparation of recombinant interferon
FR2397191A1 (en) STABLE PREPARATION OF CHLORAMPHENICOL FOR INJECTIONS
FR1302321A (en) Water-insoluble dyes and their preparation
BE862598A (en) SULFOSUCCINIC ACID DERIVATIVES THAT CAN BE USED AS EMULSIONING AGENTS IN EMULSION POLYMERIZATIONS
ATE67406T1 (en) PREPARATION FOR INJECTION CONTAINING NICORANDIL.
JPS6434909A (en) Cosmetic
ITMI920710A0 (en) SAFETY SYRINGE WITH RETRACTABLE NEEDLE AFTER USE SO AS TO AVOID REUSE OF THE SYRINGE AND THE SPREAD OF CONTAGIOUS DISEASES DUE TO ACCIDENTAL NEEDLE PICKS.
FR2571364B1 (en) NEW PROCESS FOR THE PREPARATION OF N, NON-DISUBSTITUTED NITROPARAPHENYLENEDIAMINES N, NEW OXAZOLIDONES USED IN THIS PROCESS, NEW NITROPARAPHENYLENEDIAMINES N, N'-DISUBSTITUEES OBTAINED BY THIS PROCESS AND COMPOSITIONS TINCTUTINE
GB8629639D0 (en) Composition & method
Ramer et al. Ocular penetration of pilocarpine: the effect of pH on the ocular penetration of pilocarpine
NL7511662A (en) PROCESS FOR THE PREPARATION OF 1-SUBSTITUTED DERIVATIVES OF 6'N-METHYL-3'-4'-DIDEOXYKANAMYCIN B, AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT.
BE618249A (en) Water-insoluble azo dyes, method of preparation and application
IT8024862A0 (en) THE THERAPEUTIC APPLICATION OF 4,5,6,7-TETRAHYDROISOXAZOLE (5,4-C)PIRIDIN-3-OL DERIVATIVES AS ANALGESIC AGENTS
FR1431174A (en) Water-insoluble styrylic dyes and method of preparation
SU391832A1 (en) PREPARATION
FR1333119A (en) Water-insoluble azo dyes, method of preparation and application
Fidurov et al. Clinico-functional and morphological characteristics of the stomach in patients with vibration disease
HUEHNS et al. Reaction of Hæ moglobin αA with Hæ moglobin H
IT8022114V0 (en) SYRINGE FOR THE INJECTION OF MEDICINAL PRODUCTS IN SOLUTION TO BE PREPARED AT THE MOMENT OF USE.
Golikov et al. Effect of no-spa on the level of liver glucocorticoid receptors and on the biochemical indices of homeostasis in adrenalectomized rats
ES386775A1 (en) Urea derivative preparation
Mansurov et al. Effect of the sodium salt of galbanic acid on erythrocyte aggregation in an experiment

Legal Events

Date Code Title Description
ST Notification of lapse